Shibo Qi

707 total citations
21 papers, 610 citations indexed

About

Shibo Qi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Shibo Qi has authored 21 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Shibo Qi's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Shibo Qi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Shibo Qi collaborates with scholars based in China, United States and Norway. Shibo Qi's co-authors include Zhen Cheng, Yaqing Feng, Bao Zhang, Hongguang Liu, Han Jiang, Kai Cheng, Yanming Zhao, Jinbo Li, Yuxin Jiang and Futai Lu and has published in prestigious journals such as Journal of the American Chemical Society, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Shibo Qi

20 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shibo Qi China 12 188 168 159 142 122 21 610
Deyue Yan China 15 231 1.2× 151 0.9× 70 0.4× 170 1.2× 103 0.8× 52 781
Nisarg Soni South Korea 11 150 0.8× 106 0.6× 96 0.6× 323 2.3× 224 1.8× 19 596
Ritika Uppal United States 13 495 2.6× 95 0.6× 387 2.4× 122 0.9× 124 1.0× 15 980
Yaxin Shi China 14 358 1.9× 62 0.4× 241 1.5× 249 1.8× 97 0.8× 26 716
Dongban Duan China 12 197 1.0× 103 0.6× 199 1.3× 236 1.7× 61 0.5× 13 550
Gordon Winter Germany 12 117 0.6× 91 0.5× 180 1.1× 79 0.6× 67 0.5× 29 455
Maite Jauregui‐Osoro United Kingdom 15 118 0.6× 148 0.9× 313 2.0× 197 1.4× 154 1.3× 19 696
Ryo Yamahara Japan 11 72 0.4× 160 1.0× 69 0.4× 113 0.8× 135 1.1× 11 486
Ambika Bumb United States 10 653 3.5× 161 1.0× 260 1.6× 301 2.1× 296 2.4× 14 1.0k
Levente K. Meszaros United Kingdom 12 133 0.7× 149 0.9× 423 2.7× 201 1.4× 193 1.6× 19 870

Countries citing papers authored by Shibo Qi

Since Specialization
Citations

This map shows the geographic impact of Shibo Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibo Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibo Qi more than expected).

Fields of papers citing papers by Shibo Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibo Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibo Qi. The network helps show where Shibo Qi may publish in the future.

Co-authorship network of co-authors of Shibo Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Shibo Qi. A scholar is included among the top collaborators of Shibo Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibo Qi. Shibo Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Shibo, et al.. (2022). eMoCo: Sentence Representation Learning With Enhanced Momentum Contrast. 159–163. 1 indexed citations
2.
Wu, Hua, Yuyuan Chen, Bin Li, et al.. (2020). Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma. Biochemical Pharmacology. 184. 114353–114353. 14 indexed citations
3.
Qi, Shibo, Susan Hoppmann, Yingding Xu, & Zhen Cheng. (2019). PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules. Molecular Imaging and Biology. 21(5). 907–916. 21 indexed citations
4.
Zhao, Yanming, Shibo Qi, Zheng Niu, et al.. (2019). Robust Corrole-Based Metal–Organic Frameworks with Rare 9-Connected Zr/Hf-Oxo Clusters. Journal of the American Chemical Society. 141(36). 14443–14450. 107 indexed citations
5.
Qi, Shibo, Guangye Zhou, Kaiyue Zhang, et al.. (2017). Effect of cerium ion modifications on the photoelectrochemical properties of TiO2-based dye-sensitized solar cells. Optical Materials. 75. 102–108. 11 indexed citations
6.
7.
Zhang, Kun, Jimei Zhang, & Shibo Qi. (2015). Synthesis of nitrogen-doped, graphene-supported gold nanoparticles via a microwave irradiation method and their electrochemical properties. Research on Chemical Intermediates. 46(4). 2017–2024. 5 indexed citations
8.
Yang, Tan, Bin Li, Shibo Qi, et al.. (2014). Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo. Theranostics. 4(11). 1096–1111. 83 indexed citations
9.
Qi, Shibo, Bin Li, Yang Tan, et al.. (2014). Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice. International Journal of Molecular Sciences. 15(11). 20004–20021. 9 indexed citations
10.
Xu, Chuanrui, Yang Tan, Guangya Xiang, et al.. (2014). A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo. International Journal of Nanomedicine. 9. 4581–4581. 19 indexed citations
11.
Kasten, Benjamin B., Xiaowei Ma, Hongguang Liu, et al.. (2014). Clickable, Hydrophilic Ligand forfac-[MI(CO)3]+(M = Re/99mTc) Applied in anS-Functionalized α-MSH Peptide. Bioconjugate Chemistry. 25(3). 579–592. 38 indexed citations
12.
Zhao, Ping, Xiaoyang Yang, Shibo Qi, et al.. (2013). Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes. BioMed Research International. 2013. 1–11. 24 indexed citations
13.
Yang, Meng, Kai Cheng, Shibo Qi, et al.. (2013). Affibody modified and radiolabeled gold–Iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials. 34(11). 2796–2806. 110 indexed citations
14.
Zhang, Jimei, et al.. (2013). Covalent Self-Assembly of Multi-Walled Carbon Nanotubes and Gold Nanoparticles for Detecting DNA Sequences of Genetically Modified Corn. Asian Journal of Chemistry. 25(18). 10535–10540. 2 indexed citations
15.
Miao, Zheng, Gang Ren, Hongguang Liu, et al.. (2012). PET of EGFR Expression with an 18F-Labeled Affibody Molecule. Journal of Nuclear Medicine. 53(7). 1110–1118. 56 indexed citations
16.
Hoppmann, Susan, Shibo Qi, Zheng Miao, et al.. (2012). 177Lu–DO3A–HSA–ZEGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas. JBIC Journal of Biological Inorganic Chemistry. 17(5). 709–718. 7 indexed citations
17.
Xu, Yingding, Wei Huang, Gang Ren, et al.. (2012). A Four-Arm Star-Shaped Poly(ethylene glycol) (StarPEG) Platform for Bombesin Peptide Delivery to Gastrin-Releasing Peptide Receptors in Prostate Cancer. ACS Macro Letters. 1(6). 753–757. 8 indexed citations
18.
Jiang, Han, Benjamin B. Kasten, Hongguang Liu, et al.. (2012). Novel, Cysteine-Modified Chelation Strategy for the Incorporation of [MI(CO)3]+ (M = Re, 99mTc) in an α-MSH Peptide. Bioconjugate Chemistry. 23(11). 2300–2312. 21 indexed citations
19.
Qi, Shibo, et al.. (2012). Evaluation of Four Affibody-Based Near-Infrared Fluorescent Probes for Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors. Bioconjugate Chemistry. 23(6). 1149–1156. 1 indexed citations
20.
Qi, Shibo. (2006). Research on Integration of the Six Sigma Management and the Quality Management System.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026